Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)

NCT: NCT06432881 · COMPLETED

NCT IDNCT06432881
StatusCOMPLETED
Start Date2024-01-08
Completion2026-07-07
SponsorMasimo Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the performance of Masimo RD SET® SpO2 sensors in subjects with light and dark skin pigmentation in the intensive care therapeutic area.

Frequently Asked Questions

What is Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)?

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE) is a clinical trial registered under NCT06432881. Current status: COMPLETED.

What is the status of NCT06432881?

The current status of NCT06432881 (Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)) is: COMPLETED.

When did Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE) start?

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE) started on 2024-01-08.

Related Devices

K162675Masimo Rainbow SET Intellivue Module Pulse CO-OximeterMasimo Corporation K232389Carescape SpO2 - Masimo; Masimo rainbow SET IntelliVueMasimo Corporation K173976Masimo Acoustic Respiration Sensors, infant and neonateMasimo Corporation K181956Masimo MightySat Rx Fingertip Pulse OximeterMasimo Corporation K182887Masimo Rad-67 Pulse CO-Oximeter and AccessoriesMasimo Corporation

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑